menu
    • menu

    Company profile for Minghui Pharmaceutical

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Minghui Pharmaceutical is a global biopharmaceutical company dedicated to developing innovative medicines for the benefit of patients with diseases of largely unmet medical needs. Leveraging our expertise in medical science and the proprietary technology platforms, we are developing a rich clinical-stage pipeline including a variety of first-in-class or best-in-class drug candidates. We are committed to serving patients around...
    Minghui Pharmaceutical is a global biopharmaceutical company dedicated to developing innovative medicines for the benefit of patients with diseases of largely unmet medical needs. Leveraging our expertise in medical science and the proprietary technology platforms, we are developing a rich clinical-stage pipeline including a variety of first-in-class or best-in-class drug candidates. We are committed to serving patients around the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Minghui PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 6305, Building 6, 338 Jialilue Road, Pilot Free Trade Zone, Pudong New A...
    Telephone
    Telephone
    +86 021-60898367
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.minghuipharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Minghui Pharmaceutical Announces $131 Million Pre-IPO Financing
    Minghui Pharmaceutical Announces $131 Million Pre-IPO Financing

    07 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/minghui-pharmaceutical-announces-131-million-pre-ipo-financing/

    CONTRACTPHARMA
    07 Aug 2025
    Share Share
    Minghui Doses First Patient in NSCLC Combo Therapy Trial
    Minghui Doses First Patient in NSCLC Combo Therapy Trial

    20 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minghui-pharmaceutical-announces-first-patient-dosed-in-the-phase--combination-study-of-pd-1xvegf-bispecific-and-trop-2-adc-in-advanced-nsclc-302460254.html

    PR NEWSWIRE
    20 May 2025
    Share Share
    Minghui Pharma Partners with Qilu to develop B7-H3 ADC in China
    Minghui Pharma Partners with Qilu to develop B7-H3 ADC in China

    09 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minghui-pharmaceutical-announces-strategic-partnership-and-licensing-agreement-with-qilu-pharmaceutical-to-develop-b7-h3-adc-in-greater-china-302450962.html

    PR NEWSWIRE
    09 May 2025
    Share Share
    Minghui Pharma Announces Phase I Results of MHB039A for Tumors
    Minghui Pharma Announces Phase I Results of MHB039A for Tumors

    06 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minghui-pharmaceutical-announces-promising-initial-results-from-phase-i-clinical-trial-of-mhb039a-a-novel-pd-1-x-vegf-bispecific-antibody-in-patients-with-relapsedrefractory-solid-tumors-302297285.html

    PR NEWSWIRE
    06 Nov 2024
    Share Share
    Minghui Announces Positive Results From Phase Ib/II Trial For TED
    Minghui Announces Positive Results From Phase Ib/II Trial For TED

    22 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minghui-pharmaceutical-inc-announces-positive-topline-results-from-phase-ibii-clinical-trial-of-mhb018a-a-subcutaneous-single-domain-igf-1r-antibody-in-patients-with-active-moderate-to-severe-thyroid-eye-disease-ted-302282769.html

    PR NEWSWIRE
    22 Oct 2024
    Share Share
    China-based biotech plans ph. 3 after seeing midstage eye data
    China-based biotech plans ph. 3 after seeing midstage eye data

    22 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/minghuis-thyroid-eye-disease-drug-slashes-eye-bulging-midstage-trial

    FIERCE BIOTECH
    22 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search